 Saccharomyces cerevisiae
"Saccharomyces cerevisiae" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of the genus SACCHAROMYCES, family Saccharomycetaceae, order Saccharomycetales, known as "baker's" or "brewer's" yeast. The dried form is used as a dietary supplement.
| Descriptor ID |
D012441
|
| MeSH Number(s) |
B01.300.107.795.785.800 B01.300.930.705.655
|
| Concept/Terms |
Saccharomyces cerevisiae- Saccharomyces cerevisiae
- cerevisiae, Saccharomyces
- Yeast, Baker's
- Yeast, Baker
- Yeast, Bakers
- Baker Yeast
- Baker Yeasts
- Yeasts, Baker
- Yeast, Brewer's
- Yeast, Brewer
- Yeast, Brewers
- S cerevisiae
- cerevisiae, S
- Baker's Yeast
- Baker's Yeasts
- Bakers Yeast
- Yeasts, Baker's
- Brewer's Yeast
- Brewer Yeast
- Brewer's Yeasts
- Brewers Yeast
- Yeasts, Brewer's
|
Below are MeSH descriptors whose meaning is more general than "Saccharomyces cerevisiae".
Below are MeSH descriptors whose meaning is more specific than "Saccharomyces cerevisiae".
This graph shows the total number of publications written about "Saccharomyces cerevisiae" by people in Harvard Catalyst Profiles by year, and whether "Saccharomyces cerevisiae" was a major or minor topic of these publication.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 3 | 1 | 4 | | 1981 | 10 | 2 | 12 | | 1982 | 5 | 0 | 5 | | 1983 | 21 | 3 | 24 | | 1984 | 17 | 1 | 18 | | 1985 | 15 | 3 | 18 | | 1986 | 12 | 5 | 17 | | 1987 | 21 | 5 | 26 | | 1988 | 26 | 3 | 29 | | 1989 | 25 | 5 | 30 | | 1990 | 30 | 5 | 35 | | 1991 | 33 | 17 | 50 | | 1992 | 34 | 16 | 50 | | 1993 | 27 | 15 | 42 | | 1994 | 31 | 27 | 58 | | 1995 | 36 | 22 | 58 | | 1996 | 35 | 24 | 59 | | 1997 | 36 | 36 | 72 | | 1998 | 39 | 41 | 80 | | 1999 | 54 | 51 | 105 | | 2000 | 39 | 38 | 77 | | 2001 | 37 | 46 | 83 | | 2002 | 49 | 38 | 87 | | 2003 | 46 | 49 | 95 | | 2004 | 54 | 49 | 103 | | 2005 | 51 | 39 | 90 | | 2006 | 54 | 34 | 88 | | 2007 | 42 | 30 | 72 | | 2008 | 65 | 22 | 87 | | 2009 | 66 | 26 | 92 | | 2010 | 49 | 42 | 91 | | 2011 | 63 | 33 | 96 | | 2012 | 55 | 41 | 96 | | 2013 | 69 | 28 | 97 | | 2014 | 40 | 37 | 77 | | 2015 | 30 | 31 | 61 | | 2016 | 43 | 22 | 65 | | 2017 | 28 | 20 | 48 |
To return to the timeline, click here.
Below are the most recent publications written about "Saccharomyces cerevisiae" by people in Profiles.
-
Almozlino Y, Atias N, Silverbush D, Sharan R. ANAT 2.0: reconstructing functional protein subnetworks. BMC Bioinformatics. 2017 Nov 16; 18(1):495.
-
Jarosz DF, Khurana V. Specification of Physiologic and Disease States by Distinct Proteins and Protein Conformations. Cell. 2017 Nov 16; 171(5):1001-1014.
-
Soares LM, He PC, Chun Y, Suh H, Kim T, Buratowski S. Determinants of Histone H3K4 Methylation Patterns. Mol Cell. 2017 Nov 16; 68(4):773-785.e6.
-
Garone C, D'Souza AR, Dallabona C, Lodi T, Rebelo-Guiomar P, Rorbach J, Donati MA, Procopio E, Montomoli M, Guerrini R, Zeviani M, Calvo SE, Mootha VK, DiMauro S, Ferrero I, Minczuk M. Defective mitochondrial rRNA methyltransferase MRM2 causes MELAS-like clinical syndrome. Hum Mol Genet. 2017 Nov 01; 26(21):4257-4266.
-
Joo YJ, Ficarro SB, Soares LM, Chun Y, Marto JA, Buratowski S. Downstream promoter interactions of TFIID TAFs facilitate transcription reinitiation. Genes Dev. 2017 11 01; 31(21):2162-2174.
-
Newby GA, Kiriakov S, Hallacli E, Kayatekin C, Tsvetkov P, Mancuso CP, Bonner JM, Hesse WR, Chakrabortee S, Manogaran AL, Liebman SW, Lindquist S, Khalil AS. A Genetic Tool to Track Protein Aggregates and Control Prion Inheritance. Cell. 2017 Nov 02; 171(4):966-979.e18.
-
Chen YC, Farzadfard F, Gharaei N, Chen WCW, Cao J, Lu TK. Randomized CRISPR-Cas Transcriptional Perturbation Screening Reveals Protective Genes against Alpha-Synuclein Toxicity. Mol Cell. 2017 Oct 05; 68(1):247-257.e5.
-
Hinshaw SM, Makrantoni V, Harrison SC, Marston AL. The Kinetochore Receptor for the Cohesin Loading Complex. Cell. 2017 Sep 21; 171(1):72-84.e13.
-
Cao S, Smith LL, Padilla-Lopez SR, Guida BS, Blume E, Shi J, Morton SU, Brownstein CA, Beggs AH, Kruer MC, Agrawal PB. Homozygous EEF1A2 mutation causes dilated cardiomyopathy, failure to thrive, global developmental delay, epilepsy and early death. Hum Mol Genet. 2017 09 15; 26(18):3545-3552.
-
Manning BD. Game of TOR - The Target of Rapamycin Rules Four Kingdoms. N Engl J Med. 2017 Sep 28; 377(13):1297-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|